Business Description
Tianda Pharmaceuticals Ltd
ISIN : KYG887471038
Compare
Compare
Traded in other countries / regions
00455.Hong Kong IPO Date
1992-03-30Description
Tianda Pharmaceuticals Ltd is engaged in R&D, manufactures and sales of pharmaceutical, biotechnology and healthcare products. The group also engages in R&D of Chinese medicine and manufacture and sales of Chinese medicine products, and the provision of Chinese medical services. Its operating segments include Chinese medicine business; Medical and healthcare services; and Pharmaceuticals and medical technologies business. The company derives majority of the revenue from Pharmaceuticals and medical technologies business.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.43 | |||||
| Equity-to-Asset | 0.65 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -5.48 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 1.72 | |||||
| Beneish M-Score | -2.44 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 2.6 | |||||
| 3-Year EBITDA Growth Rate | -25.6 | |||||
| 3-Year FCF Growth Rate | 1.8 | |||||
| 3-Year Book Growth Rate | -6.5 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.69 | |||||
| 9-Day RSI | 55.52 | |||||
| 14-Day RSI | 55.83 | |||||
| 6-1 Month Momentum % | 13.64 | |||||
| 12-1 Month Momentum % | 25 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.1 | |||||
| Quick Ratio | 0.89 | |||||
| Cash Ratio | 0.52 | |||||
| Days Inventory | 87.32 | |||||
| Days Sales Outstanding | 62.01 | |||||
| Days Payable | 138.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.98 | |||||
| 3-Year Dividend Growth Rate | 44.2 | |||||
| Forward Dividend Yield % | 0.98 | |||||
| 5-Year Yield-on-Cost % | 0.53 | |||||
| Shareholder Yield % | 0.98 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 48.02 | |||||
| Operating Margin % | -4.59 | |||||
| Net Margin % | -4.54 | |||||
| FCF Margin % | -21.81 | |||||
| ROE % | -4.05 | |||||
| ROA % | -2.56 | |||||
| ROIC % | -3.19 | |||||
| ROC (Joel Greenblatt) % | -5.03 | |||||
| ROCE % | -3.28 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.07 | |||||
| PB Ratio | 0.95 | |||||
| Price-to-Tangible-Book | 1.2 | |||||
| EV-to-EBIT | -25.11 | |||||
| EV-to-EBITDA | -25.11 | |||||
| EV-to-Revenue | 0.98 | |||||
| EV-to-FCF | -4.58 | |||||
| Price-to-Median-PS-Value | 0.78 | |||||
| Price-to-Net-Current-Asset-Value | 26.5 | |||||
| Earnings Yield (Greenblatt) % | -3.98 | |||||
| FCF Yield % | -20.37 | |||||
| Forward Rate of Return (Yacktman) % | 16.39 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Tianda Pharmaceuticals Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 532.089 | ||
| EPS (TTM) (HK$) | -0.011 | ||
| Beta | 0.18 | ||
| Volatility % | 32.46 | ||
| 14-Day RSI | 55.83 | ||
| 14-Day ATR (HK$) | 0.005762 | ||
| 20-Day SMA (HK$) | 0.25885 | ||
| 12-1 Month Momentum % | 25 | ||
| 52-Week Range (HK$) | 0.173 - 0.28 | ||
| Shares Outstanding (Mil) | 2,150.04 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Tianda Pharmaceuticals Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Tianda Pharmaceuticals Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Tianda Pharmaceuticals Ltd Frequently Asked Questions
What is Tianda Pharmaceuticals Ltd(HKSE:00455)'s stock price today?
The current price of HKSE:00455 is HK$0.27. The 52 week high of HKSE:00455 is HK$0.28 and 52 week low is HK$0.17.
When is next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455)?
The next earnings date of Tianda Pharmaceuticals Ltd(HKSE:00455) is .
Does Tianda Pharmaceuticals Ltd(HKSE:00455) pay dividends? If so, how much?
The Dividend Yield %  of Tianda Pharmaceuticals Ltd(HKSE:00455) is 0.98% (As of Today), Highest Dividend Payout Ratio of Tianda Pharmaceuticals Ltd(HKSE:00455) was 3. The lowest was 0.31. And the median was 1. The  Forward Dividend Yield % of Tianda Pharmaceuticals Ltd(HKSE:00455) is 0.98%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers